SNS Financial Group’s Elevance Health ELV Stock Holding History

SNS Financial Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.94M	Buy	+5,012	New	+$1.86M	0.04%	226

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

SNS Financial Group's ELV Position: Q2 2026 in Review

SNS Financial Group opened a new position in Elevance Health (ELV) in Q2 2026: 5,012 shares worth $1.94M. The stake represents 0.04% of the portfolio and ranks #226 among its holdings.

1,092 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

SNS Financial Group held 5,012 shares of Elevance Health worth $1.94M as of Q2 2026.
Elevance Health was a new SNS Financial Group position in Q2 2026.
Elevance Health made up 0.04% of SNS Financial Group's portfolio in Q2 2026, its #226 holding.
1,092 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.